Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention


  Free Subscription


1 Arch Virol
3 Epidemiol Infect
2 J Epidemiol Community Health
1 J Exp Med
11 J Infect
3 MMWR Morb Mortal Wkly Rep
2 PLoS Comput Biol
18 PLoS One
1 Proc Natl Acad Sci U S A
13 Vaccine
1 Virology

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Arch Virol

  1. DEGIUSEPPE JI, Martelli A, Barrios Mathieur C, Stupka JA, et al
    Genetic diversity of rotavirus A in Argentina during 2019-2022: detection of G6 strains and insights regarding its dissemination.
    Arch Virol. 2023;168:251.
    PubMed         Abstract available


    How can I support my colleague returning to work with long covid?
    BMJ. 2023;382:p1997.

  3. DEAN E
    What happens inside a long covid clinic?
    BMJ. 2023;382:1791.

    Epidemiol Infect

  4. SZEKELY J, Rakchang W, Rattanaphan P, Kositpantawong N, et al
    Fluconazole and echinocandin resistance of Candida species in invasive candidiasis at a university hospital during pre-COVID-19 and the COVID-19 outbreak.
    Epidemiol Infect. 2023;151:e146.
    PubMed         Abstract available

  5. LOVE NK, Douglas A, Gharbia S, Hughes H, et al
    Understanding the impact of the COVID-19 pandemic response on GI infection surveillance trends in England, January 2020-April 2022.
    Epidemiol Infect. 2023;151:e147.
    PubMed         Abstract available

  6. JENNINGS S, Corrin T, Waddell L
    A systematic review of the evidence on the associations and safety of COVID-19 vaccination and post COVID-19 condition.
    Epidemiol Infect. 2023;151:e145.
    PubMed         Abstract available

    J Epidemiol Community Health

  7. AMELE S, Kibuchi E, McCabe R, Pearce A, et al
    Ethnic inequalities in positive SARS-CoV-2 tests, infection prognosis, COVID-19 hospitalisations and deaths: analysis of 2 years of a record linked national cohort study in Scotland.
    J Epidemiol Community Health. 2023;77:641-648.
    PubMed         Abstract available

  8. BOUKARI Y, Beale S, Nguyen V, Fong WLE, et al
    SARS-CoV-2 infections in migrants and the role of household overcrowding: a causal mediation analysis of Virus Watch data.
    J Epidemiol Community Health. 2023;77:649-655.
    PubMed         Abstract available

    J Exp Med

  9. RUTERBUSCH MJ, Hondowicz BD, Takehara KK, Pruner KB, et al
    Allergen exposure functionally alters influenza-specific CD4+ Th1 memory cells in the lung.
    J Exp Med. 2023;220:e20230112.
    PubMed         Abstract available

    J Infect

  10. DANIAL-FARRAN N, Khlaila M, Avraham-Kelbert M, Chazan B, et al
    Genetic Variant in Complement Receptor 1 (CR1, CD35) is Associated with A Cluster of Severe Fatal COVID-19 in a Family.
    J Infect. 2023 Mar 14:S0163-4453(23)00143-3. doi: 10.1016/j.jinf.2023.

  11. HSU WH, Shiau BW, Tsai YW, Wu JY, et al
    The effect of molnupiravir on post-acute outcome of COVID-19 survivors.
    J Infect. 2023 Mar 21:S0163-4453(23)00145-7. doi: 10.1016/j.jinf.2023.

  12. NAMGUNG SH, Jung J, Kim SK, Kim EO, et al
    Incidence of tuberculosis infection in healthcare workers in high-risk departments for tuberculosis after universal wearing of KF94 mask during COVID-19 pandemic.
    J Infect. 2023 Mar 21:S0163-4453(23)00146-9. doi: 10.1016/j.jinf.2023.

  13. MOHN KG, Bredholt G, Onyango TB, Brokstad KA, et al
    SARS-CoV-2 infection induces long-lived B and T-cell responses up to 15 months post-infection, irrespective of disease severity.
    J Infect. 2023 Jun 7:S0163-4453(23)00302-X. doi: 10.1016/j.jinf.2023.

  14. WU JY, Hsu WH, Tsai YW, Liu TH, et al
    The association between zinc deficiency, and clinical outcomes of COVID-19.
    J Infect. 2023 Jun 29:S0163-4453(23)00343-2. doi: 10.1016/j.jinf.2023.

    Artificial Intelligence, Machine Learning and Deep Learning: Potential Resources for the Infection Clinician.
    J Infect. 2023 Jul 17:S0163-4453(23)00379-1. doi: 10.1016/j.jinf.2023.
    PubMed         Abstract available

  16. PIERANGELI A, Nenna R, Fracella M, Scagnolari C, et al
    Genetic diversity and its impact on disease severity in respiratory syncytial virus subtype-A and -B bronchiolitis before and after pandemic restrictions in Rome.
    J Infect. 2023 Jul 24:S0163-4453(23)00381-X. doi: 10.1016/j.jinf.2023.
    PubMed         Abstract available

  17. SUN B, Gao F
    Investigation of escape mechanisms of SARS-CoV-2 Omicron sub-lineages and exploration of potential antibodies for XBB.1.
    J Infect. 2023 Jul 26:S0163-4453(23)00387-0. doi: 10.1016/j.jinf.2023.

  18. FAUSTINI SE, Cook A, Hill H, Al-Taei S, et al
    Saliva antiviral antibody levels are detectable but correlate poorly with serum antibody levels following SARS-CoV-2 infection and/or vaccination.
    J Infect. 2023 Aug 3:S0163-4453(23)00439-5. doi: 10.1016/j.jinf.2023.
    PubMed         Abstract available

  19. WHITAKER HJ, Tsang RS, Byford R, Aspden C, et al
    COVID-19 vaccine effectiveness against hospitalisation and death of people in clinical risk groups during the Delta variant period: English primary care network cohort study.
    J Infect. 2023 Aug 12:S0163-4453(23)00456-5. doi: 10.1016/j.jinf.2023.
    PubMed         Abstract available

  20. CHEN JM, Tan SM, Chen RX, Gong HY, et al
    Distribution and risks of the infections of humans and other mammals with H5 subtype highly pathogenic avian influenza viruses in 2020-2023.
    J Infect. 2023 Sep 7:S0163-4453(23)00505-4. doi: 10.1016/j.jinf.2023.


  21. ABBASI J
    What to Know About EG.5, the Latest SARS-CoV-2 "Variant of Interest".
    JAMA. 2023 Aug 18. doi: 10.1001/jama.2023.16498.

  22. HARRIS E
    Lung Transplants for COVID-19 Similarly Successful.
    JAMA. 2023 Aug 23. doi: 10.1001/jama.2023.15450.

  23. HARRIS E
    Two New Analyses Add to Long COVID Understanding.
    JAMA. 2023;330:905-906.

    MMWR Morb Mortal Wkly Rep

  24. FOWLKES AL, Nogareda F, Regan A, Loayza S, et al
    Interim Effectiveness Estimates of 2023 Southern Hemisphere Influenza Vaccines in Preventing Influenza-Associated Hospitalizations - REVELAC-i Network, March-July 2023.
    MMWR Morb Mortal Wkly Rep. 2023;72:1010-1015.

  25. DEJONGE PM, Adams C, Pray I, Schussman MK, et al
    Wastewater Surveillance Data as a Complement to Emergency Department Visit Data for Tracking Incidence of Influenza A and Respiratory Syncytial Virus - Wisconsin, August 2022-March 2023.
    MMWR Morb Mortal Wkly Rep. 2023;72:1005-1009.
    PubMed         Abstract available

  26. MASRESHA BG, Hatcher C, Lebo E, Tanifum P, et al
    Progress Toward Measles Elimination - African Region, 2017-2021.
    MMWR Morb Mortal Wkly Rep. 2023;72:985-991.
    PubMed         Abstract available

    PLoS Comput Biol

  27. NASH RK, Bhatt S, Cori A, Nouvellet P, et al
    Estimating the epidemic reproduction number from temporally aggregated incidence data: A statistical modelling approach and software tool.
    PLoS Comput Biol. 2023;19:e1011439.
    PubMed         Abstract available

  28. BOSSE NI, Abbott S, Cori A, van Leeuwen E, et al
    Scoring epidemiological forecasts on transformed scales.
    PLoS Comput Biol. 2023;19:e1011393.
    PubMed         Abstract available

    PLoS One

  29. JOOSTEN SA, Smeets MJR, Arbous MS, Mannien J, et al
    Daily disease severity in patients with COVID-19 admitted to the hospital: The SCODA (severity of coronavirus disease assessment) score.
    PLoS One. 2023;18:e0291212.
    PubMed         Abstract available

  30. VALLY Z, Helmy M, Fourie L
    The association between depression and addictive social media use during the COVID-19 pandemic: The mediating role of sense of control.
    PLoS One. 2023;18:e0291034.
    PubMed         Abstract available

  31. WU M, Liu S, Wang C, Wu Y, et al
    Risk factors for mortality among lung cancer patients with covid-19 infection: A systematic review and meta-analysis.
    PLoS One. 2023;18:e0291178.
    PubMed         Abstract available

  32. KARANJA S, Aduda J, Thuo R, Wamunyokoli F, et al
    Utilization of digital tools to enhance COVID-19 and tuberculosis testing and linkage to care: A cross-sectional evaluation study among Bodaboda motorbike riders in the Nairobi Metropolis, Kenya.
    PLoS One. 2023;18:e0290575.
    PubMed         Abstract available

  33. JAFARY F, Joozdani FA, Shahzamani K, Jafari S, et al
    Different aspects in explaining how mutations could affect the binding mechanism of receptor binding domain of SARS-CoV-2 spike protein in interaction with ACE2.
    PLoS One. 2023;18:e0291210.
    PubMed         Abstract available

  34. KOPPLIN N, Garcia A, Reczek A, Wilkinson K, et al
    Post-acute sequelae of COVID-19 and longitudinal antibody levels in a community-based cohort.
    PLoS One. 2023;18:e0291259.
    PubMed         Abstract available

  35. HERATI H, Burns KE, Nascimento M, Brown P, et al
    Canadians' trust in government in a time of crisis: Does it matter?
    PLoS One. 2023;18:e0290664.
    PubMed         Abstract available

  36. AKINSEINDE SA, Kosemani S, Osuolale E, Cesare N, et al
    Association between wealth, insurance coverage, urban residence, median age and COVID-19 deaths across states in Nigeria.
    PLoS One. 2023;18:e0291118.
    PubMed         Abstract available

  37. MEYERSON WU, Hoyle RH
    Pre-pandemic activity on a myalgic encephalomyelitis/chronic fatigue syndrome support forum is highly associated with later activity on a long COVID support forum for a variety of reasons: A mixed methods study.
    PLoS One. 2023;18:e0291173.
    PubMed         Abstract available

  38. SU M
    Modelling sovereign credit ratings and assessing the impartiality: A case study of China.
    PLoS One. 2023;18:e0289321.
    PubMed         Abstract available

  39. AMARTTAYAKONG L, Ruengyangmee S, Nualkim W, Meelam P, et al
    An analysis of pain intensity, injury incidence, and their associations with socio-demographic factors in high school athletes: A cross-sectional study during the COVID-19 pandemic.
    PLoS One. 2023;18:e0290587.
    PubMed         Abstract available

  40. NARANJO D, Kimball E, Nelson J, Samore M, et al
    Differences in perceptions and acceptance of COVID-19 vaccination between vaccine hesitant and non-hesitant persons.
    PLoS One. 2023;18:e0290540.
    PubMed         Abstract available

  41. YU JR, Wei CH, Lai CJ, Lee WY, et al
    Extending the Omega model with momentum and reversal strategies to intraday trading.
    PLoS One. 2023;18:e0291119.
    PubMed         Abstract available

  42. NEIRA ALVAREZ M, Navarro Jimenez G, Anguita Sanchez N, Del Mar Bermejo Olano M, et al
    Vitamin D deficiency and SARS?CoV?2 infection: A retrospective case-Control study with big-data analysis covering March 2020 to March 2021.
    PLoS One. 2023;18:e0277388.
    PubMed         Abstract available

  43. ZEITOUNY S, Cheung DC, Bremner KE, Pataky RE, et al
    The impact of the early COVID-19 pandemic on healthcare system resource use and costs in two provinces in Canada: An interrupted time series analysis.
    PLoS One. 2023;18:e0290646.
    PubMed         Abstract available

  44. TOLBA AH, Muse AH, Fayomi A, Baaqeel HM, et al
    The Gull Alpha Power Lomax distributions: Properties, simulation, and applications to modeling COVID-19 mortality rates.
    PLoS One. 2023;18:e0283308.
    PubMed         Abstract available

  45. SEKINE M, Aune D, Nojiri S, Watanabe M, et al
    Cross-sectional study on public health knowledge among first-year university students in Japan: Implications for educators and educational institutions.
    PLoS One. 2023;18:e0291414.
    PubMed         Abstract available

  46. VAN WILLIGEN HDG, Wynberg E, Verveen A, Dijkstra M, et al
    One-fourth of COVID-19 patients have an impaired pulmonary function after 12 months of disease onset.
    PLoS One. 2023;18:e0290893.
    PubMed         Abstract available

    Proc Natl Acad Sci U S A

  47. GUSEMAN AJ, Rennick LJ, Nambulli S, Roy CN, et al
    Targeting spike glycans to inhibit SARS-CoV2 viral entry.
    Proc Natl Acad Sci U S A. 2023;120:e2301518120.
    PubMed         Abstract available


  48. CAMPBELL J, Kaur A, Gamino D, Benoit E, et al
    Individual and structural determinants of COVID-19 vaccine uptake in a marginalized community in the United States.
    Vaccine. 2023 Aug 5:S0264-410X(23)00923-4. doi: 10.1016/j.vaccine.2023.
    PubMed         Abstract available

  49. VERJOVSKY M, Barreto MP, Carmo I, Coutinho B, et al
    Political quarrel overshadows vaccination advocacy: How the vaccine debate on Brazilian Twitter was framed by anti-vaxxers during Bolsonaro administration.
    Vaccine. 2023 Aug 5:S0264-410X(23)00921-0. doi: 10.1016/j.vaccine.2023.
    PubMed         Abstract available

  50. BAGLIVO F, Magri M, De Angelis L, Aprile V, et al
    Performance comparison between heterologous and homologous COVID19 vaccine schedules on Omicron variant incidence: A real-world retrospective cohort study in Southern Italy.
    Vaccine. 2023 Aug 9:S0264-410X(23)00886-1. doi: 10.1016/j.vaccine.2023.
    PubMed         Abstract available

  51. MONTEIRO HS, Lima Neto AS, Kahn R, Sousa GS, et al
    Impact of CoronaVac on Covid-19 outcomes of elderly adults in a large and socially unequal Brazilian city: A target trial emulation study.
    Vaccine. 2023;41:5742-5751.
    PubMed         Abstract available

  52. WITTAWATMONGKOL O, Bunjoungmanee P, Kosalaraksa P, Laoprasopwattana K, et al
    Immunogenicity and reactogenicity of fractional, heterologous primary COVID-19 vaccination schedules with BNT162b2 boosters in 5-11-year-old Thai children: A multicenter, prospective, double-blind, randomized control trial.
    Vaccine. 2023 Aug 14:S0264-410X(23)00953-2. doi: 10.1016/j.vaccine.2023.
    PubMed         Abstract available

  53. NELSON CB, Brady BL, Richards M, Lew CR, et al
    Optimal site of care for administration of extended half-life respiratory syncytial virus (RSV) antibodies to infants in the United States (US).
    Vaccine. 2023;41:5820-5824.
    PubMed         Abstract available

  54. ZUR M, Shelef L, Glassberg E, Fink N, et al
    Are intelligent people more likely to get vaccinated? The association between COVID-19 vaccine adherence and cognitive profiles.
    Vaccine. 2023 Aug 15:S0264-410X(23)00951-9. doi: 10.1016/j.vaccine.2023.
    PubMed         Abstract available

  55. MORRISON K, Cullen L, James AB, Chua V, et al
    Predictors of incomplete COVID-19 vaccine schedule among adults in Scotland: Two retrospective cohort analyses of the primary schedule and third dose.
    Vaccine. 2023 Aug 17:S0264-410X(23)00916-7. doi: 10.1016/j.vaccine.2023.
    PubMed         Abstract available

  56. CHAIWONG W, Takheaw N, Pata S, Laopajon W, et al
    Neutralizing antibody and T-cell responses against SARS-CoV-2 variants by heterologous CoronaVac/ChAdOx-1 vaccination in elderly subjects with chronic obstructive pulmonary disease.
    Vaccine. 2023 Aug 18:S0264-410X(23)00966-0. doi: 10.1016/j.vaccine.2023.
    PubMed         Abstract available

  57. YAO T, Guo Y, Xu X, Zhang X, et al
    Predictors of immune persistence induced by two-dose BBIBP-CorV vaccine in high-risk occupational population.
    Vaccine. 2023 Aug 19:S0264-410X(23)00974-X. doi: 10.1016/j.vaccine.2023.
    PubMed         Abstract available

  58. MOHAMMED IS, Widome R, Searle KM
    COVID-19 vaccine decision-making among Black women: A qualitative study.
    Vaccine. 2023 Aug 24:S0264-410X(23)00920-9. doi: 10.1016/j.vaccine.2023.
    PubMed         Abstract available

  59. YU J, Sreenivasan C, Sheng Z, Zhai SL, et al
    A recombinant chimeric influenza virus vaccine expressing the consensus H3 hemagglutinin elicits broad hemagglutination inhibition antibodies against divergent swine H3N2 influenza viruses.
    Vaccine. 2023 Sep 7:S0264-410X(23)01060-5. doi: 10.1016/j.vaccine.2023.
    PubMed         Abstract available

  60. POTT H, Andrew MK, Shaffelburg Z, Nichols MK, et al
    Vaccine Effectiveness of non-adjuvanted and adjuvanted trivalent inactivated influenza vaccines in the prevention of influenza-related hospitalization in older adults: A pooled analysis from the Serious Outcomes Surveillance (SOS) Network of the Canad
    Vaccine. 2023 Sep 9:S0264-410X(23)01026-5. doi: 10.1016/j.vaccine.2023.
    PubMed         Abstract available


  61. TEWARI DN, Biswas A, Chakrabarti AK, Dutta S, et al
    AMFR promotes innate immunity activation and proteasomal degradation of HMGCR in response to influenza virus infection in A549 cells.
    Virology. 2023;587:109875.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Influenza is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.